| Earnings (Loss) Per Share The following table sets forth the computation of basic and diluted earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
| (in thousands, except per share data) |
2023 |
|
2022 |
|
2023 |
|
2022 |
| Numerator: |
|
|
|
|
|
|
|
| Net income (loss) from continuing operations |
$ |
(12,769) |
|
|
$ |
3,105 |
|
|
$ |
(18,466) |
|
|
$ |
23,934 |
|
| Net loss from discontinued operations |
$ |
(5,163) |
|
|
$ |
(2,481) |
|
|
$ |
(19,301) |
|
|
$ |
(1,993) |
|
| Net income (loss) |
$ |
(17,932) |
|
|
$ |
624 |
|
|
$ |
(37,767) |
|
|
$ |
21,941 |
|
| Denominator: |
|
|
|
|
|
|
|
| Weighted-average common shares outstanding |
10,135 |
|
|
10,253 |
|
|
10,151 |
|
|
10,235 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
| Employee stock options and stock grants |
— |
|
|
212 |
|
|
— |
|
|
172 |
|
| Weighted-average common shares, as adjusted |
10,135 |
|
|
10,465 |
|
|
10,151 |
|
|
10,407 |
|
|
|
|
|
|
|
|
|
| Net income (loss) per share from continuing operations: |
|
|
|
|
|
|
|
| Basic |
$ |
(1.26) |
|
|
$ |
0.30 |
|
|
$ |
(1.82) |
|
|
$ |
2.34 |
|
| Diluted |
$ |
(1.26) |
|
|
$ |
0.30 |
|
|
$ |
(1.82) |
|
|
$ |
2.30 |
|
|
|
|
|
|
|
|
|
| Net loss per share from discontinued operations: |
|
|
|
|
|
|
|
| Basic |
$ |
(0.51) |
|
|
$ |
(0.24) |
|
|
$ |
(1.90) |
|
|
$ |
(0.19) |
|
| Diluted |
$ |
(0.51) |
|
|
$ |
(0.24) |
|
|
$ |
(1.90) |
|
|
$ |
(0.19) |
|
|
|
|
|
|
|
|
|
| Net income (loss) per share: |
|
|
|
|
|
|
|
| Basic |
$ |
(1.77) |
|
|
$ |
0.06 |
|
|
$ |
(3.72) |
|
|
$ |
2.14 |
|
| Diluted |
$ |
(1.77) |
|
|
$ |
0.06 |
|
|
$ |
(3.72) |
|
|
$ |
2.11 |
|
The diluted earnings (loss) per share calculations exclude the effect of potentially dilutive shares when the inclusion of those shares in the calculation would have an anti-dilutive effect. The Company had 0.1 million shares that were anti-dilutive for the three and nine months ended September 30, 2023. The Company had an immaterial number of shares that were anti-dilutive for the three and nine months ended September 30, 2022.
|